C4 Therapeutics stockholders elect three Class I directors, approve say-on-pay, ratify KPMG

C4 Therapeutics, Inc.

Kenneth Anderson re-elected with 38.0M for, 8.6M withheld; Laura Bessen with 37.7M for, 8.8M withheld; Owen Hughes with 27.5M for, 19.1M withheld.
Advisory say-on-pay passed: 34.5M for, 11.9M against, 0.1M abstain.
KPMG LLP ratified as independent auditor for FY2024: 54.4M for, 0.2M against, 0 abstain.
No other matters were voted on at the annual meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.